Quick Answer
BIO-PATH HOLDINGS, INC. reported Research And Development Expense of $7.30 million for the year ending 2024.
- BIO-PATH HOLDINGS, INC. showed a decrease of -37.2% in Research And Development Expense from 2023 to 2024.
- This data is from BIO-PATH HOLDINGS, INC.'s annual report (Form 10-K), filed with the SEC on March 27, 2025.
- XBRL data for this metric is available from 2012 to 2024 (14 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Over the full 14 years of available data (2012 to 2024), BIO-PATH HOLDINGS, INC.'s Research And Development Expense has grown by 544.0%.
- Historical annual values: Fiscal year 2024: $7.30 million | Fiscal year 2023: $11.61 million | Fiscal year 2022: $9.17 million | Fiscal year 2021: $5.91 million | Fiscal year 2020: $6.58 million | Fiscal year 2019: $4.59 million | Fiscal year 2018: $4.60 million | Fiscal year 2017: $5.48 million | Fiscal year 2016: $5.47 million | Fiscal year 2015: $3.02 million | Fiscal year 2014: $1.63 million | Fiscal year 2014: $1.63 million | Fiscal year 2013: $1.52 million | Fiscal year 2012: $1.13 million.
- Data sourced from SEC EDGAR public filings as of June 20, 2026.
Last verified: